GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
77
c/survodutide·posted 2 months ago by u/lyophile_lou

[Results] 28 weeks, 11kg, and MASH was the hard part

Discussion

28 weeks, 11kg, and MASH was the hard part. Same spreadsheet I have been keeping since the start, nothing retrofitted.

Since the title puts numbers in the shop window: 28 weeks and 11kg.

Asked here what the difference was between the imaging and biopsy endpoints and got a genuinely excellent answer.

Looked for independent results across this whole site and found almost none. Worth knowing before forming an opinion.

Happy to answer the boring questions. Those are usually the ones worth asking.

110 up / 33 down77% upvoted14 commentsid s580rd9 May 2026

14 comments

14 in this archive, depth 3

best — the order this archive was captured in

u/nora_ramos-32 points·2 months ago

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use.

replysharereportpermalink
[removed]1 point·2 months ago

[removed by moderator]

replysharereportpermalink
u/mod_cold_roommod · c/coldchain1 point·2 months ago

phase 2 in liver disease is a different evidence question from weight

replysharereportpermalink
u/customs_seizure_sid1 point·2 months ago

fibrosis improvement without worsening steatohepatitis is the phrase to learn

replysharereportpermalink
u/kaia_wojcik1 point·2 months ago

Agreed that the endpoint definitions matter enormously and almost nobody reads them before quoting a response rate.

replysharereportpermalink
u/cato_batista1 point·2 months ago

dual GLP-1 and glucagon agonist, and the glucagon arm is the story

replysharereportpermalink
u/kaia_kuusela10 points·2 months ago

Imaging-derived liver fat fraction is a surrogate. It correlates with histology imperfectly, and a trial reporting one is not reporting the other.

replysharereportpermalink
u/yannick_petrov5 points·2 months ago·edited

Disagree — that is a weight endpoint from a different programme and you are quoting it in a hepatic context.

replysharereportpermalink
u/lyophile_louOP2 points·2 months ago

Is that a weight number from a different programme?

replysharereportpermalink
u/kasper_cabrera4 points·2 months ago

Yes — nothing containing this is approved anywhere, which is the first fact and usually the last one mentioned.

replysharereportpermalink
u/fibre_forward2 points·2 months ago

This. Biopsy-confirmed and imaging-suggested are different evidentiary categories and get run together constantly.

replysharereportpermalink
u/incretin_ivyMOD7 points·2 months ago

Retitled to name the endpoint. Histological and imaging results are not interchangeable and the original title implied they were.

replysharereportpermalink
u/peak_area_peteanalytical4 points·2 months ago

Retitled to name the endpoint.

This is the framing the board needs. It is a hepatic programme first.

replysharereportpermalink
u/honest_syringe_pls3 points·2 months ago

That is an escalation schedule for an unapproved compound and this board does not host those.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.